Prognostic value of the timing of immune checkpoint inhibitors infusion in patients with advanced hepatocellular carcinoma

被引：0
|
作者：
Pascale, Alina [1 ]
Allard, Marc Antoine [2 ]
Benamar, Amal [1 ]
Levy, Francis [2 ]
Adam, Rene [2 ]
Rosmorduc, Olivier [3 ]
机构：
[1] CHU Paul Brousse, AP HP, Villejuif, France
[2] Univ Paris Saclay, CHU Paul Brousse, AP HP, Villejuif, France
[3] Paris Sorbonne Univ, CHU Paul Brousse, AP HP, Villejuif, France
来源：
JOURNAL OF HEPATOLOGY | 2024年 / 80卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
THU-491
引用
收藏
页码：S452 / S452
页数：1
相关论文
共 50 条
  • [41] Hepatocellular carcinoma immune prognosis score predicts the clinical outcomes of hepatocellular carcinoma patients receiving immune checkpoint inhibitors
    Rujia Zhang
    Haoran Zhao
    Peng Wang
    Zuoming Guo
    Chunxun Liu
    Zhaowei Qu
    BMC Cancer, 23
  • [42] Hepatocellular carcinoma immune prognosis score predicts the clinical outcomes of hepatocellular carcinoma patients receiving immune checkpoint inhibitors
    Zhang, Rujia
    Zhao, Haoran
    Wang, Peng
    Guo, Zuoming
    Liu, Chunxun
    Qu, Zhaowei
    BMC CANCER, 2023, 23 (01)
  • [43] The safety and efficacy of lenvatinib combined with immune checkpoint inhibitors therapy for advanced hepatocellular carcinoma
    Wang, Yun
    Jiang, Man
    Zhu, Jingjuan
    Qu, Jialin
    Qin, Kang
    Zhao, Deze
    Wang, Li
    Dong, Lina
    Zhang, Xiaochun
    BIOMEDICINE & PHARMACOTHERAPY, 2020, 132
  • [44] Outcomes of beta blocker use in advanced hepatocellular carcinoma treated with immune checkpoint inhibitors
    Wu, Y. Linda
    van Hyfte, Grace
    Ozbek, Umut
    Reincke, Marlene
    Gampa, Anuhya
    Mohamed, Yehia I.
    Nishida, Naoshi
    Wietharn, Brooke
    Amara, Suneetha
    Lee, Pei-Chang
    Scheiner, Bernhard
    Balcar, Lorenz
    Pinter, Matthias
    Vogel, Arndt
    Weinmann, Arndt
    Saeed, Anwaar
    Pillai, Anjana
    Rimassa, Lorenza
    Naqash, Abdul Rafeh
    Muzaffar, Mahvish
    Huang, Yi-Hsiang
    Kaseb, Ahmed O.
    Kudo, Masatoshi
    Pinato, David J.
    Ang, Celina
    FRONTIERS IN ONCOLOGY, 2023, 13
  • [45] Prognostic significance of psoas muscle index in male hepatocellular carcinoma patients treated with immune checkpoint inhibitors and tyrosine kinase inhibitors
    Luo, Ning
    Li, Hu
    Luo, Yindeng
    Hu, Peng
    Liang, Luwen
    Zhang, Rong
    Zhang, Dazhi
    Cai, Dachuan
    Kang, Juan
    HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2023, 19 (02)
  • [46] Ipilimumab and nivolumab/pembrolizumab in advanced hepatocellular carcinoma refractory to prior immune checkpoint inhibitors
    Wong, Jeffrey Sum Lung
    Kwok, Gerry Gin Wai
    Tang, Vikki
    Li, Bryan Cho Wing
    Leung, Roland
    Chiu, Joanne
    Ma, Ka Wing
    She, Wong Hoi
    Tsang, Josephine
    Lo, Chung Mau
    Cheung, Tan To
    Yau, Thomas
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2021, 9 (02)
  • [47] Emerging immune checkpoint inhibitors for the treatment of hepatocellular carcinoma
    Chan, Landon L.
    Chan, Stephen L.
    EXPERT OPINION ON EMERGING DRUGS, 2021, 26 (01) : 39 - 51
  • [48] Unraveling the Complexities of Immune Checkpoint Inhibitors in Hepatocellular Carcinoma
    Han, Xinpu
    Sun, Qianhui
    Xu, Manman
    Zhu, Guanghui
    Gao, Ruike
    Ni, Baoyi
    Li, Jie
    SEMINARS IN LIVER DISEASE, 2023, 43 (04) : 383 - 401
  • [49] Hepatocellular carcinoma and immunotherapy: Beyond immune checkpoint inhibitors
    Hassan Mohammed Abushukair
    Anwaar Saeed
    World Journal of Gastrointestinal Oncology, 2022, 14 (06) : 1210 - 1212
  • [50] Cancer Immunotherapy - Immune Checkpoint Inhibitors in Hepatocellular Carcinoma
    Bai, Jing
    Liang, Ping
    Li, Qian
    Feng, Rui
    Liu, Jiang
    RECENT PATENTS ON ANTI-CANCER DRUG DISCOVERY, 2021, 16 (02) : 239 - 248
12345